Abstract
Objective:
The maternally imprinted insulin-like growth factor 2 (IGF2) gene is an important fetal growth factor and is also suggested to have postnatal metabolic effects. In this study, we examined whether common polymorphisms in IGF2 (6815_6819delAGGGC, 1156T>C and 820G>A (ApaI)) and a microsatellite marker in the close vicinity of IGF2 were linked to or associated with birth weight and adult metabolic risk factors.
Design and participants:
Polymorphisms were genotyped in 199 monozygotic complete twin pairs, 109 dizygotic complete twin pairs, 15 single twins, 231 mothers and 228 fathers recruited from the East Flanders Prospective Twin Survey. Conventional and parent-of-origin specific linkage and association analyses were carried out with birth weight, adult body height and parameters quantifying obesity, insulin sensitivity and dyslipidaemia measured at adult age (mean age 25 years).
Results:
In the parent-of-origin specific association analysis, in which only the paternally inherited allele was incorporated, the 1156T>C SNP (single nucleotide polymorphism) showed significant association with IGF-binding protein 1 (IGFBP1) levels (T and C (mean (95% CI)): 13.2 (12.1–14.3) and 16.2 (14.6–18.0) ng ml−1, P=0.002). No linkage was observed in either the conventional or in the parent-of-origin specific linkage analysis.
Conclusion:
This study suggests that paternally inherited alleles of a common polymorphism in the IGF2 gene affect IGFBP1 levels.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van Dijk MA, van Schaik FM, Bootsma HJ, Holthuizen P, Sussenbach JS . Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol Cell Endocrinol 1991; 81: 81–94.
Monk D, Sanches R, Arnaud P, Apostolidou S, Hills FA, Abu-Amero S et al. Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet 2006; 15: 1259–1269.
Pham NV, Nguyen MT, Hu JF, Vu TH, Hoffman AR . Dissociation of IGF2 and H19 imprinting in human brain. Brain Res 1998; 810: 1–8.
Vu TH, Hoffman AR . Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 1994; 371: 714–717.
Wu HK, Squire JA, Song Q, Weksberg R . Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues. Biochem Biophys Res Commun 1997; 233: 221–226.
DeChiara TM, Efstratiadis A, Robertson EJ . A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345: 78–80.
Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL . Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994; 8: 2953–2963.
Gicquel C, Le Bouc Y . Hormonal regulation of fetal growth. Horm Res 2006; 65 (Suppl 3): 28–33.
Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005; 37: 1003–1007.
Delaval K, Wagschal A, Feil R . Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. Bioessays 2006; 28: 453–459.
Weksberg R, Shuman C, Smith AC . Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2005; 137: 12–23.
Rossetti L, Barzilai N, Chen W, Harris T, Yang D, Rogler CE . Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem 1996; 271: 203–208.
Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994; 269: 13779–13784.
Kadlecova M, Dobesová Z, Zicha J, Kunes J . Abnormal Igf2 gene in Prague hereditary hypertriglyceridemic rats: its relation to blood pressure and plasma lipids. Mol Cell Biochem 2008; 314: 37–43.
Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, Moreau L et al. A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 2003; 425: 832–836.
Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ . Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes 2003; 52: 1403–1408.
Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L et al. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes. Am J Med 2006; 119: 167 e9–e15.
Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM . Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62–67.
Hattersley AT, Tooke JE . The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353: 1789–1792.
O’Dell SD, Bujac SR, Miller GJ, Day IN . Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity. Eur J Hum Genet 1999; 7: 821–827.
O’Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H et al. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 1997; 21: 822–825.
Bachner-Melman R, Zohar AH, Nemanov L, Heresco-Levy U, Gritsenko I, Ebstein RP . Association between the insulin-like growth factor 2 gene (IGF2) and scores on the Eating Attitudes Test in nonclinical subjects: a family-based study. Am J Psychiatry 2005; 162: 2256–2262.
Sayer AA, Syddall H, O'Dell SD, Chen XH, Briggs PJ, Briggs R et al. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 2002; 31: 468–470.
t Hart LM, Fritsche A, Rietveld I, Dekker JM, Nijpels G, Machicao F et al. Genetic factors and insulin secretion: gene variants in the IGF genes. Diabetes 2004; 53 (Suppl 1): S26–S30.
Gomes MV, Soares MR, Pasqualim-Neto A, Marcondes CR, Lôbo RB, Ramos ES . Association between birth weight, body mass index and IGF2/ApaI polymorphism. Growth Horm IGF Res 2005; 15: 360–362.
Roth SM, Schrager MA, Metter EJ, Riechman SE, Fleg JL, Hurley BF et al. IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord 2002; 26: 585–587.
Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD . Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 2001; 10: 1491–1501.
Heude B, Ong KK, Luben R, Wareham NJ, Sandhu MS . Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women. J Clin Endocrinol Metab 2007; 92: 2734–2738.
Kaku K, Osada H, Seki K, Sekiya S . Insulin-like growth factor 2 (IGF2) and IGF2 receptor gene variants are associated with fetal growth. Acta Paediatr 2007; 96: 363–367.
Loos R, Derom C, Vlietinck R, Derom R . The East Flanders Prospective Twin Survey (Belgium): a population-based register. Twin Res 1998; 1: 167–175.
Souren NY, Paulussen AD, Loos RJ, Gielen M, Beunen G, Fagard R et al. Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia 2007; 50: 2107–2116.
Abecasis GR, Cherny SS, Cookson WO, Cardon LR . Merlin—rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97–101.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
Neale MC, Boker SM, Xie G, Maes HH . Mx: Statistical Modeling, 6th edn, VCU Department of Psychiatry: Richmond, VA, 2002.
Souren NY, Zeegers MP, Janssen RG, Steyls A, Gielen M, Loos RJ et al. Anthropometry, Carbohydrate and Lipid Metabolism in the East Flanders Prospective Twin Survey: linkage of candidate genes using two sib-pair based variance components analyses. Twin Res Hum Genet 2008; 11: 505–516.
Lindsay RS, Kobes S, Knowler WC, Hanson RL . Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of birth weight. Hum Genet 2002; 110: 503–509.
Akaike H . A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716–723.
Laird NM, Horvath S, Xu X . Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19 (Suppl 1): S36–S42.
Horvath S, Xu X, Laird NM . The family based association test method: strategies for studying general genotype—phenotype associations. Eur J Hum Genet 2001; 9: 301–306.
Janssen JA, Lamberts SW . The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol 2002; 146: 467–477.
Mohan S, Baylink DJ . IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 2002; 175: 19–31.
Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD . Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355–1360.
Lee PD, Giudice LC, Conover CA, Powell DR . Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997; 216: 319–357.
Heald A, Stephens R, Gibson JM . The insulin-like growth factor system and diabetes—an overview. Diabet Med 2006; 23 (Suppl 1): 19–24.
Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K . Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia 2008; 51: 1135–1145.
Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 2001; 44: 333–339.
Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K . IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. Diabetes Care 2007; 30: 2343–2348.
Lee PD, Suwanichkul A, DePaolis LA, Snuggs MB, Morris SL, Powell DR . Insulin-like growth factor (IGF) suppression of IGFBP-1 production: evidence for mediation by the type I IGF receptor. Regul Pept 1993; 48: 199–206.
Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK . Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest 1988; 81: 976–981.
Chao W, D’Amore PA . IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008; 19: 111–120.
Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F et al. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest 1986; 78: 249–258.
Li X, Cui H, Sandstedt B, Nordlinder H, Larsson E, Ekström TJ . Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters. J Endocrinol 1996; 149: 117–124.
Rodriguez S, Gaunt TR, Day IN . Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease. Hum Genet 2007; 122: 1–21.
Acknowledgements
This work was financially supported by the Dutch Diabetes Research Foundation (DFN 2002.00.15) and the National Fund for Scientific Research Flanders (G.3.0269.97; G.0383.03). The EFPTS has been partly supported by grants from Funds of Scientific Research Flanders and by Twins, the Association for Scientific Research in Multiple Births Belgium. We are grateful to all the twins and their parents participating in this study. We thank Ingeborg Berckmoes, Annie Roossens, Lut De Zeure and Margaret Van Heuverswyn for fieldwork and technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on International Journal of Obesity website (http://www.nature.com/ijo)
Supplementary information
Rights and permissions
About this article
Cite this article
Souren, N., Paulussen, A., Steyls, A. et al. Parent-of-origin specific linkage and association of the IGF2 gene region with birth weight and adult metabolic risk factors. Int J Obes 33, 962–970 (2009). https://doi.org/10.1038/ijo.2009.126
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2009.126